{"title":"It's hard enough having cancer as an adolescent or young adult, but what about its financial impact?","authors":"Samantha Watson","doi":"10.1007/s11764-026-02089-z","DOIUrl":null,"url":null,"abstract":"<p><p>The financial challenges of the author as a young adult were discussed. These costs were further made worse because of a second cancer diagnosis and treatment only a few years later. The health matters and their economic burden occurred while in college, which also presented a significant cost. This \"survivor perspective\" also goes on to describe a valuable resource for financial toxicity developed by the author as a way to truly pay it forward: The SAMFund (now part of Expect Miracles Foundation). The author describes the financial strain of other young adult cancer survivors who actually received funding from her organization. Samantha then discusses a \"second wave\" of costs that go beyond the acute costs of treatment. These are the persistent costs related to cancer survivorship. This 25-year cancer survivor provides a personal perspective on the long-term financial impact of cancer in those with a history of cancer as an adolescent or young adult.</p>","PeriodicalId":15284,"journal":{"name":"Journal of Cancer Survivorship","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Survivorship","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11764-026-02089-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The financial challenges of the author as a young adult were discussed. These costs were further made worse because of a second cancer diagnosis and treatment only a few years later. The health matters and their economic burden occurred while in college, which also presented a significant cost. This "survivor perspective" also goes on to describe a valuable resource for financial toxicity developed by the author as a way to truly pay it forward: The SAMFund (now part of Expect Miracles Foundation). The author describes the financial strain of other young adult cancer survivors who actually received funding from her organization. Samantha then discusses a "second wave" of costs that go beyond the acute costs of treatment. These are the persistent costs related to cancer survivorship. This 25-year cancer survivor provides a personal perspective on the long-term financial impact of cancer in those with a history of cancer as an adolescent or young adult.
期刊介绍:
Cancer survivorship is a worldwide concern. The aim of this multidisciplinary journal is to provide a global forum for new knowledge related to cancer survivorship. The journal publishes peer-reviewed papers relevant to improving the understanding, prevention, and management of the multiple areas related to cancer survivorship that can affect quality of care, access to care, longevity, and quality of life. It is a forum for research on humans (both laboratory and clinical), clinical studies, systematic and meta-analytic literature reviews, policy studies, and in rare situations case studies as long as they provide a new observation that should be followed up on to improve outcomes related to cancer survivors. Published articles represent a broad range of fields including oncology, primary care, physical medicine and rehabilitation, many other medical and nursing specialties, nursing, health services research, physical and occupational therapy, public health, behavioral medicine, psychology, social work, evidence-based policy, health economics, biobehavioral mechanisms, and qualitative analyses. The journal focuses exclusively on adult cancer survivors, young adult cancer survivors, and childhood cancer survivors who are young adults. Submissions must target those diagnosed with and treated for cancer.